In: Accounting
Exercise 12-22 (Algo) Equity method; adjustment for depreciation [LO12-6, 12-7]
Fizer Pharmaceutical paid $81 million on January 2, 2021, for 3
million shares of Carne Cosmetics common stock. The investment
represents a 20% interest in the net assets of Carne and gave Fizer
the ability to exercise significant influence over Carne’s
operations. Fizer received dividends of $2 per share on December
21, 2021, and Carne reported net income of $40 million for the year
ended December 31, 2021. The fair value of Carne’s common stock at
December 31, 2021, was $31.50 per share.
Required:
Complete the table below and prepare the appropriate journal
entries related to the investment during 2021.
Compute the undervaluation of Asset as follows ( in millions) | |||||||
Investee Net Asset | Ownership Interest | = | Net Asset Purchased | Difference | Attributable to | ||
Purchase Price | 81 | ||||||
Fair Value of C Asset (205+45) | 250 | X | 20% | = | 50 | 81-50 = 31 | Goodwill |
Book Value of C Asset | 205 | X | 20% | = | 41 | 50-41 = 9 | Undervaluation of Asset |
Journal Entry in the Books of Fizer Pharmaceutical ( in Million) | |||
Date | particulars | Debit | Credit |
jan 2 |
Investment in Carne Cosmetic | 81 | |
2021 | Cash | 81 | |
( To record Purchase of Investment) | |||
dec-21 | Cash (3*2) | 6 | |
2021 | Investment in Carne Cosmetic | 6 | |
( To record Dividend received) | |||
dec-31 | Investment in Carne Cosmetic | 8 | |
2021 | Investment Revenue (40*20%) | 8 | |
( To record share of income) | |||
dec-31 | Investment Revenue ($9million /9 Year) | 1 | |
2021 | Investment in Carne Cosmetic | 1 | |
(To Record depreciation adjustment for Undervaluation ) |